Affiliation:
1. Department of Pathophysiology, Key Lab for Shock and Microcirculation Research of Guangdong, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
Abstract
In recent years, it has been established that atherosclerosis is an autoimmune disease. However, little is currently known about the role of FcγRIIA in atherosclerosis. Herein, we sought to investigate the relationship between FcγRIIA genotypes and the effectiveness of different IgG subclasses in treating atherosclerosis. We constructed and produced different subtypes of IgG and Fc-engineered antibodies. In vitro, we observed the effect of different subtypes of IgG and Fc-engineered antibodies on the differentiation of CD14+ monocytes from patients or healthy individuals. In vivo, Apoe−/− mice were fed a high-fat diet (HFD) for 20 weeks and administered injections of different CVI-IgG subclasses or Fc-engineered antibodies. Flow cytometry was used to assess the polarization of monocytes and macrophages. Although CVI-IgG4 reduced the release of MCP-1 compared to the other subtypes, IgG4 did not yield an anti-inflammatory effect by induction of human monocyte and macrophage differentiation in vitro. Furthermore, genetic polymorphisms of FcγRIIA were not associated with different CVI-IgG subclasses during the treatment of atherosclerosis. In vivo, CVI-IgG1 decreased Ly6Chigh monocyte differentiation and promoted M2 macrophage polarization. We also found that the secretion of IL-10 was upregulated in the CVI-IgG1-treated group, whereas V11 and GAALIE exerted no significant effect. These findings highlight that IgG1 is the optimal subtype for treating atherosclerosis, and CVI-IgG1 can induce monocyte/macrophage polarization. Overall, these results have important implications for the development of therapeutic antibodies.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangdong
Guangdong Province Talent Recruitment Foundation and the Guangdong Innovative Research Team Program
Guangzhou Science and technology project
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference59 articles.
1. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences;Fredrikson;Arterioscler. Thromb. Vasc. Biol.,2003
2. ApoB-100 and HSP60 peptides exert a synergetic role in inhibiting early atherosclerosis in immunized ApoE-null mice;Li;Protein Pept. Lett.,2011
3. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis;To;Cardiovasc. Res.,2011
4. Matsuura, E., Atzeni, F., Sarzi-Puttini, P., Turiel, M., Lopez, L.R., and Nurmohamed, M.T. (2014). Is atherosclerosis an autoimmune disease?. BMC Med., 12.
5. Atherosclerosis. the road ahead;Glass;Cell,2001